Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

17 best payday loans online: Quick cash and fast approval this Christmas

If you face a financial emergency, traditional loans may not be a viable option if you have bad credit. So what can you do when you need quick cash – especially close if you need cash for Christmas gifts during the festive season? The best online payday loans are an a...
Dominic Castleberry | December 11, 2023 |

Voxtur is the Leading Provider of Digital, SaaS Solutions for Real Estate Transactions in N. America

Before we dive into what makes Voxtur Analytics ( TSX-V: VXTR ; OTCQB: VXTRF) a standout PropTech company (and an undervalued investment opportunity), it’s worth highlighting a few recent developments: –Voxtur has seen revenues increase 300% year-over-year a...
Stockhouse Editorial | September 22, 2021 |

Standard Lithium Arranges C$5 Million Convertible Loan Financing

The Critical Investor delves into a lithium company's financing and its implications. It seems more and more likely that Standard Lithium Ltd. (SLL:TSX.V; STLHF:OTCQX; FRA: S5L) is displaying a serious commitment of giant JV partner Lanxess these days, with constr...
Streetwise Reports | November 6, 2019 |

Barrick Gold, Desert Gold, Gazprom: Using volatility wisely

The stock exchange is not a one-way street, and for this reason, there are also fluctuations in price formation. There is no such thing as a fair valuation that statically determines the value of a share. Every investor has different motives in investment decisions and about t...
Mario Hose | October 2, 2020 |

We Should Let the Banks Burn Down

Bob Moriarty of 321 Gold explains why he believes banks should be allowed to fail. In later 2008 during what is now referred to as the Great Financial Crisis, government and financial managers had an opportunity to reset a badly out of balance banking system....
Streetwise Reports | August 7, 2019 |

G2 Energy: focused on joining the top ranks of mid-tier junior oil and gas producers

Welcome to the Market Herald, I’m Simon Druker and you’re watching the Top Line. G2 Energy is involved in acquiring existing oil and gas assets, primarily in oil-rich Texas. The Vancouver-based energy company remains focused on joining ...
Simon Druker | April 24, 2023 |

Why Fortune Favours Chris Taylor’s Kodiak Copper

It’s a stark new reality. And investors need to listen up or lose out. Truth be told, it is no longer only the size and grade of each new mineral discovery that determines whether it can become a mine. Now, all exploration/development projects also need to ...
Marc Davis | January 24, 2022 |

Benefactor of Interest Rate Cuts

Last week for the first time since 2008, the Federal Reserve cut interest rates. But was this rate cut needed? The Fed has been trying to force feed consumers who contribute about 70% to GDP to keep borrowing and spending. The plan has been working thus far as the economic e...
Dr. Kal Kotecha | August 7, 2019 |

FDA Accepts NDA for Global Blood Therapeutics' Sickle Cell Drug; Shares Up 14%

Shares of Global Blood Therapeutics are trading more than 14% higher after the FDA accepted its New Drug Application filing for Voxelotor, a drug used in the treatment of sickle cell disease. Earlier today clinical-stage biopharmaceutical firm Global Blood Therapeuti...
Streetwise Reports | September 6, 2019 |

Genprex Shares Soar 250% on FDA Fast Track Designation for Lung Cancer Drug

Genprex's shares spiked 380% higher in morning trading as the company reported that the FDA granted Fast Track Designation for its Oncoprex immunogene therapy in combination with EGFR inhibitor osimertinib. This morning, Genprex Inc. (GNPX:NASDAQ) , which "utilizes a...
Streetwise Reports | January 22, 2020 |
1 2 3 4